The gateway to the largest hospital in Catalonia.
The gateway to research and medical innovation.
The gateway to the oncology center of excellence.
The space for specialized and top-level care of the multiple sclerosis.
We are Vall d'Hebron
Activate and deactivate items in the key to see those that interest you.
Use the list to answer your health-related questions.
Learn more about cancer. Find out about the risk factors and specialist care we provide.
We make life easier. We can help with all administrative processes and get you the information you need during your time in hospital and...
Donate your time through a voluntary organisation or tell us about your experience at the hospital.
If you are considering where to do your residency, we can offer a wide range of clinical specialisations when you train at Vall d’Hebron...
Last year, the hospital performed 114 cornea transplants, beating its own record. The Ophthalmology Department offers all available...
Josep Gamez has worked in the Neurology Department at the Vall d’Hebron University Hospital in Barcelona since 1989. His clinical work focuses on treatment of neuromuscular disorders.
He has been the Coordinator of the Hospital’s Neuromuscular Disorders Clinic and Director of the Peripheral Nervous System Laboratory at the Vall d’Hebron Research Institute since 2008.
His main research interests are genetic aspects of neuromuscular disorders, and factors modifying clinical expression in the familial forms of ALS. His other area of interest is genetic factors in autoimmune myasthenia gravis. He has reported a new autosomal dominant form of limb girdle muscle dystrophy linked to chromosome 7q32.1-32.2 (LGMD 1F) OMIM %608423. The gene responsible (TNPO3) has recently been identified. He has authored over a hundred peer-reviewed publications and book chapters.
He is Principal Investigator or Coordinator for various grants and clinical trials, including FIS (Fondo de Investigación Sanitarias), Marató-TV3, NIH (National Institutes of Health, U.S.A.), FIPSE and SAF. These grants are for studies of rare disorders such as ALS, myasthenia gravis, PROMM or Myotonic Dystrophy Type 2, Steinert’s disease, familial amyloid polyneuropathy (Corino-Andrade’s disease), mitochondrial disorders, Huntington’s disease and chronic inflammatory demyelinating polyneuropathy (CIDP).
He is also the coordinator at Vall d’Hebron University Hospital of the European Reference Network for Neuromuscular Diseases (ERN EURO-NMD) and the head of the adults section of the European Reference Network for Rare Neurological Diseases (RND).